Sale by Eric Venker (President & Immunovant CEO)
200,000 shares · @ $29.59 · $5,918,000
Roivant Sciences Ltd. Common Shares · PHARMACEUTICAL PREPARATIONS · Now $29.09
+3.3% in 7d after detection
Post-detection moves
1h
—
1d
+1.6%
3d
+0.4%
7d
+3.3%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS